AMF Pensionsforsakring AB Continues to Hold Position in Danaher Corporation (DHR)
AMF Pensionsforsakring AB continued to hold its stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 872,037 shares of the conglomerate’s stock at the end of the second quarter. AMF Pensionsforsakring AB’s holdings in Danaher Corporation were worth $74,585,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in DHR. Regent Investment Management LLC raised its stake in shares of Danaher Corporation by 198.5% in the first quarter. Regent Investment Management LLC now owns 21,322 shares of the conglomerate’s stock valued at $1,824,000 after buying an additional 14,179 shares during the last quarter. Tompkins Financial Corp raised its stake in shares of Danaher Corporation by 3.6% in the first quarter. Tompkins Financial Corp now owns 11,087 shares of the conglomerate’s stock valued at $1,052,000 after buying an additional 387 shares during the last quarter. Fox Run Management L.L.C. raised its stake in shares of Danaher Corporation by 48.9% in the first quarter. Fox Run Management L.L.C. now owns 7,000 shares of the conglomerate’s stock valued at $599,000 after buying an additional 2,300 shares during the last quarter. Eastern Bank raised its stake in shares of Danaher Corporation by 3.1% in the first quarter. Eastern Bank now owns 2,915 shares of the conglomerate’s stock valued at $249,000 after buying an additional 87 shares during the last quarter. Finally, BLB&B Advisors LLC raised its stake in shares of Danaher Corporation by 2.2% in the first quarter. BLB&B Advisors LLC now owns 23,293 shares of the conglomerate’s stock valued at $1,992,000 after buying an additional 500 shares during the last quarter. Institutional investors and hedge funds own 76.56% of the company’s stock.
Shares of Danaher Corporation (NYSE:DHR) traded up 0.67% on Friday, hitting $79.82. 2,433,944 shares of the company traded hands. The firm’s 50 day moving average price is $82.89 and its 200-day moving average price is $84.21. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01. The stock has a market capitalization of $55.45 billion, a price-to-earnings ratio of 25.48 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.90 earnings per share. On average, equities research analysts expect that Danaher Corporation will post $3.95 earnings per share for the current year.
WARNING: This story was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.watchlistnews.com/amf-pensionsforsakring-ab-continues-to-hold-position-in-danaher-corporation-dhr/1478605.html.
Several brokerages have issued reports on DHR. Janney Montgomery Scott lowered shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. BidaskClub upgraded shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, June 21st. Deutsche Bank AG reiterated a “buy” rating and set a $97.00 target price on shares of Danaher Corporation in a research report on Wednesday, June 21st. Zacks Investment Research lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Monday, June 19th. Finally, Credit Suisse Group reiterated a “buy” rating and set a $93.00 target price on shares of Danaher Corporation in a research report on Wednesday, May 24th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $91.76.
In other news, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now owns 39,020 shares in the company, valued at $3,283,923.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now owns 18,245 shares in the company, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 38,623 shares of company stock worth $3,206,426. Insiders own 12.20% of the company’s stock.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.